Reference health

Precios Máximos De Venta En El Mercado De Medicamentos Colombiano: Una Evaluación De Impacto (Maximum Selling Prices in the Colombian Pharmaceutical Market: An Impact Evaluation)

https://doi.org/10.2139/ssrn.3265337
CiteStamped reference-health badge
17/17 checkable references clean · checked 2026-08-28

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 17 checked references that resolve
resolves10.4272/978-84-9745-065-2.ch3
La sensibilidad al precio. Implicaciones sobre el precio de referencia
resolves10.18004/rdn2015.0007.01.043-045
Perforación esofágica por cuerpo extraño
resolves10.1023/A:1012504310953
The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro Data
resolves10.1016/j.jhealeco.2009.11.015
Retail price regulation and innovation: Reference pricing in the pharmaceutical industry
resolves10.1016/j.jhealeco.2016.01.003
Health insurance and diversity of treatment
resolves10.1016/j.jpubeco.2016.03.006
The design of insurance coverage for medical products under imperfect competition
resolves10.1016/j.euroecorev.2008.03.004
Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?
resolves10.1016/j.jpubeco.2010.11.015
Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
resolves10.2307/1911698
Measuring the Effect of Subsidized Training Programs on Movements In and Out of Employment
resolves10.1007/s10198-006-0357-y
Price regulation and generic competition in the pharmaceutical market
resolves10.1016/s0167-6296(99)00039-9
Cross-national price differences for pharmaceuticals: how large, and why?
resolves10.2139/ssrn.1685213
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
resolves10.1377/hlthaff.18.6.75
Trends In Managed Care And Managed Competition, 1993–1997
resolves10.2307/3087468
Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?
resolves10.2165/00148365-200504020-00003
What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
resolves10.2165/11535360-000000000-00000
Impact of European Pharmaceutical Price Regulation on Generic Price Competition
resolves10.1016/s1574-0064(00)80038-4
Chapter 25 The pharmaceutical industry
The 10 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedref8
no DOI — not checkedref11
no DOI — not checkedReview of the Literature on Reference Pricing
no DOI — not checkedref15
no DOI — not checkedref16
no DOI — not checkedref18
no DOI — not checkedref20
no DOI — not checkedPharmaceutical spending (indicator
no DOI — not checkedref23
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-28 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.3265337"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3265337/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.3265337/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.3265337)